Intravenous fosaprepitant for the prevention of chemotherapy ‐induced vomiting in children: A double‐blind, placebo‐controlled, phase III randomized trial
ConclusionAddition of fosaprepitant to ondansetron and dexamethasone improved chemotherapy ‐induced vomiting control in children treated with moderately or highly emetogenic chemotherapy.
Source: Pediatric Blood and Cancer - Category: Cancer & Oncology Authors: Venkatraman Radhakrishnan,
Archit Joshi,
Jaikumar Ramamoorthy,
Swaminathan Rajaraman,
Prasanth Ganesan,
Trivadi S. Ganesan,
Manikandan Dhanushkodi,
Tenali G. Sagar Tags: RESEARCH ARTICLE Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Children | Dexamethasone | Eyes | Neurology | Pediatrics | Study | Zofran